3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exclusion of pregnancy in dialysis patients: diagnostic performance of human chorionic gonadotropin

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          A positive pregnancy test in acute or chronically ill patients has implications for the use of potentially mutagenic or teratogenic products in urgent medical therapies such as the use of chemotherapies or therapies with immunosuppressants, for anesthesia, and for time-sensitive indications like urgent surgery or organ Transplantation.

          Despite a lack of evidence, it is currently believed that human chorionic gonadotropin serum concentrations are always elevated in female dialysis patients even without pregnancy. It is also believed that human chorionic gonadotropin cannot be used to confirm or exclude pregnancy.

          Methods

          Human chorionic gonadotropin was examined in female dialysis patients (18–50 years of age), and was classified as positive above 5 mlU/ml. In addition, fertility status was determined. For an enhanced index test, the cut-off of 5 mIU/ml was used for potentially fertile patients and 14 mIU/ml for infertile patients to calculate diagnostic test accuracy. The ideal cut-off for human chorionic gonadotropin was estimated using Liu’s method with bootstrapped 95% confidence intervals. Predictors of human chorionic gonadotropin increase were analyzed using multivariable linear regression.

          Results

          Among 71 women, two (2.8%) were pregnant, 46 (64.8%) potentially fertile, and 23 (32.4%) infertile. We observed human chorionic gonadotropin concentrations > 5 mIU/ml in 10 patients, which had a sensitivity of 100% (95% confidence interval: 100 to 100), a specificity of 86% (95% confidence interval: 77 to 94), a positive predictive value of 17% (95% confidence interval: 8 to 25) and a negative predictive value of 100% (95% confidence interval: 100 to 100) for the diagnosis of pregnancy. Using a cut-off > 14 mIU/ml for infertile patients or the exclusion of infertile patients increased specificity to 93% or 98%, respectively. The ideal cut-off was 25 mIU/ml (95% confidence interval: 17 to 33). Pregnancy and potential fertility, but not age, were independent predictors of human chorionic gonadotropin.

          Conclusion

          Human chorionic gonadotropin is elevated > 5mIU/ml in 14.5% of non-pregnant dialysis patients of child-bearing age. In potentially fertile women, this cut-off can be used to exclude pregnancy. In case of an unknown fertility status, the ideal human chorionic gonadotropin cut-off was 25 mIU/ml.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: not found
          • Article: not found

          Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pregnancy in chronic kidney disease and kidney transplantation.

            Chronic kidney disease (CKD) affects up to 6% of women of childbearing age in high income countries, and is estimated to affect 3% of pregnant women. Advanced renal dysfunction, proteinuria, hypertension, and poorly controlled underlying primary renal disease are all significant risks for adverse maternal, fetal, and renal outcomes. In order to achieve the best outcomes, it is therefore of paramount importance that these pregnancies are planned, where possible, to allow the opportunity to counsel women and their partners in advance and to optimize these risks. These pregnancies should be deemed high risk and they require close antenatal monitoring from an expert multidisciplinary team. We discuss the effect of pregnancy on CKD, and also current guidelines and literature with specific reference to transplantation, autoimmune disease, and medication use in pregnancy. We also discuss the benefits of prepregnancy counseling and give practical recommendations to advise pregnant women with renal disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pregnancy in chronic renal insufficiency and end-stage renal disease.

              S. Hou (1999)
              Childbearing is important to women with renal disease, but pregnancy has generally been regarded as very high risk in these women. In this review, an attempt is made to clarify the nature and severity of those risks in the settings of chronic renal insufficiency and end-stage renal disease, including dialysis patients and transplant recipients. Hypertension is the most common life-threatening problem in all three groups. A wide range of antihypertensive medications have been used, with angiotensin-converting enzyme inhibitors the only drugs absolutely contraindicated because of their association with neonatal anuria, pulmonary hypoplasia, and neonatal death. Women with serum creatinine levels of 1.4 mg/dL or greater are at risk for accelerated loss of renal function compared with women who don't become pregnant. Transplant recipients have a risk for loss of renal function similar to controls as long as renal function is well preserved. The frequency of conception is decreased in women with renal insufficiency and markedly decreased in dialysis patients (0.5% per year). Return of fertility is the rule in transplant recipients. Exposure to immunosuppressive drugs, including prednisone, azathioprine, cyclosporine, and tacrolimus, has not been associated with an increase in congenital anomalies. These drugs, particularly cyclosporine, have been associated with small-for-gestational-age babies. Transplant recipients are at risk for infections that have implications for the fetus, including cytomegalovirus, herpes simplex, and toxoplasmosis. All groups have an increased risk for prematurity and intrauterine growth restriction. The percentage of pregnancies resulting in surviving infants in women with renal insufficiency and transplant recipients ranges from 70% to 100%. For women who conceive after starting dialysis, the likelihood of a surviving infant is approximately 50%.
                Bookmark

                Author and article information

                Contributors
                natalja.haninger-vacariu@meduniwien.ac.at
                Journal
                BMC Nephrol
                BMC Nephrol
                BMC Nephrology
                BioMed Central (London )
                1471-2369
                28 February 2020
                28 February 2020
                2020
                : 21
                : 70
                Affiliations
                [1 ]GRID grid.22937.3d, ISNI 0000 0000 9259 8492, Division of Nephrology and Dialysis, Department of Medicine III, , Medical University of Vienna, ; Währingergürtel 18-20, 1090 Vienna, Austria
                [2 ]GRID grid.22937.3d, ISNI 0000 0000 9259 8492, Department of Emergency Medicine, , Medical University of Vienna, ; 1090 Vienna, Austria
                [3 ]Dialysis Centre Vienna, 1220 Vienna, Austria
                [4 ]GRID grid.417109.a, ISNI 0000 0004 0524 3028, Department of Medicine VI, , Wilhelminenspital, ; 1160 Vienna, Austria
                [5 ]GRID grid.22937.3d, ISNI 0000 0000 9259 8492, Sigmund Freud Private University, Medical School, ; 1020 Vienna, Austria
                [6 ]GRID grid.490543.f, Division of Gastroenterology and Nephrology, Department of Medicine I, , Hospital St. John of God, ; 1020 Vienna, Austria
                [7 ]GRID grid.22937.3d, ISNI 0000 0000 9259 8492, Department of Laboratory Medicine, , Medical University of Vienna, ; 1090 Vienna, Austria
                [8 ]Austrian Dialysis and Transplant Registry, 4532 Rohr im Kremstal, Austria
                Author information
                http://orcid.org/0000-0001-6323-1007
                Article
                1729
                10.1186/s12882-020-01729-5
                7049197
                32111190
                7310efd7-7913-410e-9280-6c6c639c23f5
                © The Author(s) 2020

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 12 August 2019
                : 19 February 2020
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2020

                Nephrology
                anesthesia,chronic kidney disease,diagnostic accuracy,dialysis,fertility,menopause,menstrual cycle,human chorionic gonadotropin,follicle stimulating hormone,anti-müllerian hormone,immunosuppressant,kidney transplantation,pregnancy,surgery

                Comments

                Comment on this article